Cascades Capital Asset Management »

GlaxoSmithKline shares owned by Cascades Capital Asset Management

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by Cascades Capital Asset Management from 13F filings

Historical chart of Cascades Capital Asset Management investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by Cascades Capital Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by Cascades Capital Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $104k 1.9k 55.19

More positions owned by Cascades Capital Asset Management

Vanguard Dividend Appreciation ETF Equity (VIG)
Vanguard S&P 500 ETF Equity (VOO)
Vanguard S&P 500 Value Equity (VOOV)
Apple Equity (AAPL)
Microsoft Corp Equity (MSFT)
Vanguard Value ETF Equity (VTV)
Nvidia Corp Equity (NVDA)
Vanguard Growth ETF Equity (VUG)
Vanguard Mid Cap Index ETF Equity (VO)
Alphabet Inc Class A Equity (GOOGL)
I Shares 3-7 Year US Treas. ETF Equity (IEI)
S P D R S&p 500 Etf Equity (SPY)
Wisdomtree Floating Rate Treas. ETF Equity (USFR)
Powershs QQQ Nasdaq ETF Equity
Schwab Fundamental US Co. Index Equity (FNDX)

View all positions for Cascades Capital Asset Management

Top funds holding GlaxoSmithKline

Eads & Heald Investment Counsel/
Cascades Capital Asset Management
Asset Planning
Byrne Asset Management
Huntington National Bank

View all funds holding GlaxoSmithKline